Delcath Systems Inc.

(DCTH) Trade

Symbol has changed to a new ticker symbol

(DCTHD)

By |

Profile

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Contact Information

Website: www.delcath.com
Email: investorrelations@delcath.com
Main Phone: +1 212 489-2100
Address: 1633 Broadway
Address 2: 22nd Floor, Suite C
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Jennifer K. Simpson
Employees: 33
NAICS: Medical Laboratories(621511)

Equities News

Profile

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Contact Information

Website: www.delcath.com
Email: investorrelations@delcath.com
Main Phone: +1 212 489-2100
Address: 1633 Broadway
Address 2: 22nd Floor, Suite C
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Jennifer K. Simpson
Employees: 33
NAICS: Medical Laboratories(621511)

Equities News

$ 8.60 $ 0.98 (12.86%)
Last Price 8.60 Change $ 0.98 Change % 12.86 Tick N/A
Bid 8.60 Bid Size 100.00 Ask 8.65 Ask Size 200.00
Open 7.25 High 8.99 Low 7.25 Prev Close 7.62
Last Trade Volume 172,465 52 Wk Hi 63.00 52 Wk Low 5.16
Market Cap 23.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 2,760,401.00 EPS (TTM) -483.27 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Marco Taglietti 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Roger G. Stoll 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Laura A. Philips 1,000
William D. Rueckert 1,000
Last 10 Sell Shares
Krishna Kandarpa 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.3 1.3 1.3 1.3
Low Target Price Estimate 1.3 1.3 1.3 1.3
Mean Target Price Estimate 1.3 1.3 1.3 1.3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/01/13 08/01/13 08/01/13 08/01/13
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
Mean Rec. 0 0 0 5